Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

The Pain Pill Epidemic Is Hurting Newborn Babies

forbes.com — The epidemic of overuse of prescription narcotic pills may be landing as many as 15,000 newborns in the intensive care unit at an annual cost of hundreds of millions of dollars to the healthcare system, according to a new study published in the New England Journal of Medicine. "Clearly it's a [...]

When Old Drugs Are Made New Again

forbes.com — How can it be that a drug which has been on the market for more than 90 years - and is effective at slowing or even stopping the progression of a common, deadly disease - is still so costly that Americans can lose their eyesight, their kidneys, their limbs, and [...]

Start-Up Pledges To Cut Cost of Breast Cancer Genetic Testing From $4000 to $249

forbes.com — This morning, a Burlingame, Calif.-based startup called Color Genomics is announcing that it will provided genetic testing for breast and ovarian cancer - the same genetic tests that led Angelina Jolie to have her breasts and ovaries surgically removed - at one-sixteenth the cost of the main test that is [...]

Breast Cancer Cases To Increase 50% By 2030. Don't Panic.

forbes.com — Researchers at the National Cancer Institute project that the number of breast cancer cases will rise 50% to 441,000 cases a year, according to research presented at the annual meeting of the American Association for Cancer Research. Sound awful? Maybe less so than you think. The increase was driven by three [...]

Immune System Drugs Melt Tumors, Leading A Cancer Revolution

Merck Cancer Drug Shines Against Skin, Lung Cancer

forbes.com — Merck's immune-boosting cancer drug, Keytruda, bested the standard of care in advanced melanoma, the deadly skin cancer, and showed promising results in non-small cell lung cancer. Based on these data, Merck says it will file an application with the Food and Drug Administration for Keytruda to be used in non-small cell [...]

Why Supposedly Abuse-Proof Pills Won't Stop Opioid Overdose Deaths

forbes.com — Oral pain pills containing opiods have become a big business, drawing in companies including Purdue Pharma, Pfizer, and Zogenix. But they've also become a huge public health problem, leading to record numbers of drug overdose deaths. In 2013, more than 16,000 people died of opiate analgesic drug overdoses, up from [...]

I Spent Eight Years Bashing A Heart Drug. Now I Wonder: Should I Take It?

forbes.com — Over the past eight years I've written more than 100 stories criticizing a drug called ezetimibe, which is sold by itself under the brand name Zetia and in combination with an older drug under the brand Vytorin. When I started off, in 2006, it was just "the Vytorin question:" did these [...]

Biogen MS Drug Results Are 'Mildly Encouraging' In Eye Disease Test

forbes.com — Results from using Biogen's experimental nerve repair drug in a disease of the eye were "mildly encouraging," experts say, keeping alive the hope that the medicine might work in multiple sclerosis. The results will be presented next week at the 67th Annual Meeting of the American Academy of Neurology (AAN) in [...]

IBM Announces Deals With Apple, Johnson And Johnson, And Medtronic In Bid To Transform Health Care

forbes.com — Experts in health care and information technology agree on the future's biggest opportunity: the creation of a new computational model that will link together all of the massive computers that now hold medical information. The question remains: who will build it, and how? IBM is today staking its claim to be [...]
More Articles →
Apr 26, 2015

Re: $CLDN: Heart failure has always been on of the toughest areas for gene therapy. The company's previous valuation speaks to this.

Apr 26, 2015

RT @adamfeuerstein: $CLDN announced Mydicar ph2 results: Fail. Nice call by @Ogut_Ozgur on his skeptical interpretation of prior data.

Apr 26, 2015

The Overuse Of Narcotic Pills May Be Hospitalizing 15,000 Newborn Babies A Year onforb.es/1E9MVbc

Apr 25, 2015

@Bobmorevc @kevloria Yes. Also, it's possible it works as advertised. We will see.

Apr 25, 2015

Scientists are skeptical about the secret blood test that made Elizabeth Holmes billions read.bi/1JyBXgo by @kevloria

Apr 24, 2015

RT @obahcall: George Church's seminar at @NatureRevGenet @IcahnInstitute Genomics BigData & Medicine series #GBDM freely available https://…

Apr 24, 2015

RT @adamfeuerstein: $CPRX Competitor Surprises With Positive Orphan Disease Drug Study Results thestreet.com/story/13125612… Jacobus Pharma is still in LEMS hunt.

Email Matthew by joining Muck Rack Pro



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


Share This Profile